[1]
“Influence of concurrent capecitabine based chemoradiotherapy with bevacizumab on the survival rate, late toxicity and health- related quality life in locally advanced rectal cancer. A prospective phase II CRAB trial”., Radiol Oncol, vol. 54, no. 4, pp. 461–469, Nov. 2020, Accessed: Sep. 23, 2026. Available: https://radioloncol.com/index.php/ro/article/view/3424